Michaeli, D., Michaeli, C. T., Albers, S., & Michaeli, J. (2024). Patient enrollment per month (accrual) in clinical trials leading to the FDA approval of new cancer drugs. Targeted oncology, 19(5), . https://doi.org/10.1007/s11523-024-01081-w
Chicago-Zitierstil (17. Ausg.)Michaeli, Daniel, Christoph T. Michaeli, Sebastian Albers, und Julia Michaeli. "Patient Enrollment Per Month (accrual) in Clinical Trials Leading to the FDA Approval of New Cancer Drugs." Targeted Oncology 19, no. 5 (2024). https://doi.org/10.1007/s11523-024-01081-w.
MLA-Zitierstil (9. Ausg.)Michaeli, Daniel, et al. "Patient Enrollment Per Month (accrual) in Clinical Trials Leading to the FDA Approval of New Cancer Drugs." Targeted Oncology, vol. 19, no. 5, 2024, https://doi.org/10.1007/s11523-024-01081-w.